trastuzumab deruxtecan,sacituzumab
daiichi sankyo,astrazeneca,gilead sciences
['breast', 'destiny,breast,2', 'destiny,breast,4', 'mbc', 'tropics-02', 'elucida,(-elucidating)']
#esmo22 highlight: hrqol data from both tropics-02 and destiny-breast04 were shown to elucidate improvements in the qol of women with mbc, demonstrating how contemporary studies now measure hrqol as a secondary outcome leading to better understanding and utilization of measures 